Download PDF
Semin Hear 2005; 26(4): 191-201
DOI: 10.1055/s-2005-922441
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Medical Perspectives on Autism Spectrum Disorders

Ronald L. Lindsay1
  • 1Director of Research, Arizona Child Study Center, Developmental and Behavioral Pediatrics, Children's Health Center of St. Joseph's Hospital and Medical Center; Associate Professor of Clinical Pediatrics, University of Arizona Health Science Center, Tucson, Arizona
Further Information

Publication History

Publication Date:
15 November 2005 (online)

    Permissions and Reprints

ABSTRACTS

This article provides a general overview of the current diagnostic criteria and methodology for identifying children with autism. It addresses an apparent increase in the prevalence of autism and potential contributing factors to this increase. A discussion on therapeutic modalities available for the treatment of autism is offered. The roles of pediatricians and the care of children with autistic spectrum disorders, as part of an interdisciplinary team, are highlighted.

KEYWORDS

Autism spectrum disorders - Asperger disorder - applied behavioral analysis

REFERENCES

  • 1 Kanner L. Autistic disturbances of affective contact.  Nervous Child. 1943;  2 217-250
    PubMedGoogle Scholar
  • 2 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. Washington, DC; APA 1980
    Google Scholar
  • 3 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC; APA 1986
    Google Scholar
  • 4 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC; APA 1994
    Google Scholar
  • 5 Yeargin-Alsopp M, Reiss C, Karapurkar T et al.. Prevalence of autism in a US metropolitan area.  JAMA. 2003;  289 49-55
    CrossrefPubMedGoogle Scholar
  • 6 Bertrand J, Mars A, Boyle C et al.. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation.  Pediatrics. 2001;  108 1155-1161
    CrossrefPubMedGoogle Scholar
  • 7 Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children.  JAMA. 2001;  285 3093-3099
    CrossrefPubMedGoogle Scholar
  • 8 Barbaresi W R, Katusic S K, Collagen R C et al.. Explaining the apparent increase in the incidence of autism in Olmstead County Minnesota from 1976 to 1997.  J Dev Behav Pediatr. 2002;  23 398-399
    PubMedGoogle Scholar
  • 9 Barton M, Volkmar F. How commonly are known medical conditions associated with autism?.  J Autism Dev Disord. 1998;  28 273-278
    PubMedGoogle Scholar
  • 10 Bailey A, Luthert P, Dean A et al.. A clinicopathological study of autism.  Brain. 1998;  121 889-905
    CrossrefPubMedGoogle Scholar
  • 11 Kemper T L, Bauman M. Neuropathology of infantile autism.  J Neuropathol Exp Neurol. 1998;  57 645-652
    PubMedGoogle Scholar
  • 12 Nelson K B, Grether J K, Crien L A et al.. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation.  Ann Neurol. 2001;  49 597-606
    CrossrefPubMedGoogle Scholar
  • 13 Baron-Cohen S, Allen J, Gillberg C. Can autism be detected at 18 months? The needle, the haystack, and the CHAT.  Br J Psychiatry. 1992;  161 839-843
    PubMedGoogle Scholar
  • 14 Siegel B. Pervasive Developmental Disorders Screening Test-II. San Antonio, TX; Harcourt Publishing 2004
    Google Scholar
  • 15 Robins D L, Fein D, Barton M L, Green J A. The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders.  J Autism Dev Disord. 2001;  31(2) 131-144
    CrossrefPubMedGoogle Scholar
  • 16 Schopler E, Reichler R, Renner B R. The Childhood Autism Rating Scale (CARS). Austin, TX; Pro-Ed 1988
    Google Scholar
  • 17 Gilliam J E. Gilliam Autism Rating Scale (GARS). Austin, TX; Pro-Ed 1995
    Google Scholar
  • 18 Rutter M, Le Couteur A, Lord C. ADI-R Autism Diagnostic Interview-Revised. Los Angeles, CA; Western Psychological Services 2003
    Google Scholar
  • 19 Lord C, Rutter M L, Goode S et al.. Autism Diagnostic Observation Schedule: A standardized observation of communicative and social behavior.  J Autism Dev Disord. 1989;  19(2) 185-212
    PubMedGoogle Scholar
  • 20 Lovaas O I. Behavioral treatment and normal educational and intellectual functioning in young autistic children.  J Consult Clin Psychol. 1997;  55 3-9
    PubMedGoogle Scholar
  • 21 Wieder S, Greenspan S I. Climbing the symbolic ladder in the DIR model through floor time/interactive play.  Autism. 2003;  7(4) 425-435
    CrossrefPubMedGoogle Scholar
  • 22 Aman M G, Van Bourgondien M E, Wolford P L, Sarphare G. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.  J Am Acad Child Adolec Psychiatry. 1995;  34 1672-1681
    PubMedGoogle Scholar
  • 23 Langworthy-Lam K S, Aman M G, Van Bourgondien M E. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina.  J Child Adolesc Psychiatry. 2002;  12 311-321
    PubMedGoogle Scholar
  • 24 Research Units on Pediatric Psychopharmacology Autism Network . Risperidone in children with autism and serious behavioral disturbances.  N Engl J Med. 2002;  347 314-321
    CrossrefPubMedGoogle Scholar
  • 25 McDougale C J, Naylor S T, Cohen C J et al.. A double-blind, placebo-controlled study all flew Fox a mean in adults with autistic disorder.  Arch Gen Psychiatry. 1996;  53 1001-1008
    PubMedGoogle Scholar
  • 26 American Academy of Pediatrics .Complementary and alternative medicine. Available at: http://www.aap.org/visit/tfocam.htm Accessed October 14, 2005
    Google Scholar
  • 27 Aman M G, Singh N N. Vitamin, mineral, in dietary treatment. In: Aman MG, Singh NN Psychopharmacology of the Developmental Disabilities. New York; Springer-Verlag 1998: 168-196
    Google Scholar
  • 28 Kleijnen J, Knipschild P. Niacin and vitamin B-6 in mental functioning: a review of controlled trials in humans.  Biol Psychiatry. 1991;  29 931-941
    CrossrefPubMedGoogle Scholar
  • 29 Tolbert L, Haigler T, Waits M M, Dennis T. Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium.  J Autism Dev Disord. 1993;  23 193-199
    PubMedGoogle Scholar
  • 30 Findling R L, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Witznitzer M. High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutatory effects in a double-blind placebo-controlled study.  J Autism Dev Disord. 1997;  27 467-478
    PubMedGoogle Scholar
  • 31 Knivsberg A M, Reichelt K L, Hoien T, Nodland M. A randomized, controlled study of dietary intervention in autistic syndromes.  Nutr Neurosci. 2002;  5 251-261
    CrossrefPubMedGoogle Scholar
  • 32 Sponheim E. Gluten-free diet in infantile autism: a therapeutic trial.  Tidsskrift for Den Norske Laegeforening. 1991;  111 704-707
    PubMedGoogle Scholar
  • 33 Wakefield A J, Murch S H, Anthony A et al.. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and perseverative developmental disorder in children.  Lancet. 1998;  351 637-641
    CrossrefPubMedGoogle Scholar
  • 34 Murch S H, Anthony A, Casson D H et al.. Retraction of an interpretation.  Lancet. 2004;  363(9411) 750
    CrossrefPubMedGoogle Scholar
  • 35 Stratton K. Immunization safety review: thimerosal-containing vaccines and neurodevelopmental disorders. Washington, DC; National Academy Press 2001
    Google Scholar
  • 36 Lord C. Is secretin a useful treatment in autism?.  J Autism Devel Disord. 1999;  29 269
    PubMedGoogle Scholar

Ronald L LindsayM.D. 

3600 N. 3rd Ave.

Phoenix, AZ 85013

Email: rlindsay@chw.edu

      >